Open Access Government produces compelling and informative news, publications, eBooks, and academic research articles for the public and private sector looking at health, diseases & conditions, workplace, research & innovation, digital transformation, government policy, environment, agriculture, energy, transport and more.
Home 2026
Archives
Addressing the multi-billion dollar anti-infective and oncology therapeutics market
Stablepharma and AFT Pharmaceuticals (NZX: AFT; ASX: AFP) partner to address multi-billion dollar anti-infective and oncology therapeutics market.
Revolutionising global vaccine access: The case for Stablepharma’s fridge-free vaccine technology
Stablepharma is focused on improving global vaccine access with its leading candidate, SPVX02. Here, they discuss the challenges of vaccine development and distribution, and highlight how their platform could transform accessibility through fridge-free vaccines.



